Lumivatamig
Based on 1 Customer Validation
Lumivatamig is an H-γ1_L-κ-scFvhl dimer-type bispecific antibody targeting CLDN18.2 & CD3E.
For research use only. We do not sell to patients.
- Purity: 97.24%
- CAS No.: 3035406-55-1
- Molecular Weight:174.282 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
immunoglobulin (H-gamma1_L-kappa)_(H-gamma1-17merscFvlh_ L-kappa)
Human
CLDN18.2 & CD3E
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
IgG1-kappa-[scFv]1-lambda
ELISA, FACS, Functional assay
-
Immobilized CLDN18.2 Protein, Human (HEK293, HY-P78368) can bind Lumivatamig, The ED50 for this effect is 8.052 ng/mL. -
Immobilized CD3D-CD3E Heterodimer Protein, Human (HEK293, HY-P700677) can bind Lumivatamig. The ED50 for this effect is 17.85 ng/mL.
Chemical Information
-
CAS No. 3035406-55-1
-
Appearance Liquid
-
Molecular Weight 174.282 kDa
-
Color Colorless to light yellow
-
SMILES
N/A
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (254 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)